Yunfeng Shen

The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018

Qin Zhang, Shucai Xiao, Xiaojuan Jiao et al. · Cardiovascular Diabetology · 2023 · 412 citations · Full text

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

Xuan Xia, Jinhua Yan, Yunfeng Shen et al. · PLoS ONE · 2011 · 260 citations · Full text

Liver Response, Insulin Signaling, Oxidative Stress +20

Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway

Jing Zhang, Lelin Huang, Liu Yang et al. · Aging · 2020 · 251 citations · Full text

Acute Lung Injury, Heart Failure, Apoptosis +23

SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis

Yunfeng Shen, Lidan Cheng, Minxuan Xu et al. · Metabolism · 2023 · 99 citations

Hepatic Stellate Cells, Immunology, Pathology +18

Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression

Lidan Cheng, Peng Yu, Fangfang Li et al. · Human Cell · 2021 · 71 citations

Regenerative Medicine, Metabolic Syndrome, Hepatology +14